Instruction for use: Virosept

ATX code D08A Antiseptics and disinfectants

Pharmacological group

dermotropic means

Antiseptics and disinfectants

Nosological classification (ICD-10)

A60 Anogenital herpetic viral infection [herpes simplex

Herpes simplex genitalis, Banal recurrent genital herpes, Secondary genital herpes, Genital herpesvirus infection, Genital herpetic infections, Genital herpes, Herpes genitalia, Genital herpes, Herpes simplex organs, Herpetic lesions of the mucocutaneous urinary organs, Herpetic lesions of the genitals, Primary genital herpes, Primary herpes simplex, Simple herpes extragenital and genital localization, Recurrent genital herpes, Recurrent herpes of genital organs, Herpes of the lips and genitals

B00 Infections caused by the herpes simplex virus [herpes simplex]

Herpes simplex, Herpes virus, Herpes simplex virus, Herpes simplex virus type I and II, HSV, Herpes, Herpes simplex / herpes simplex /, Herpes lips, Herpes simplex, Herpes in patients with immunodeficiency, Labial herpes, Acute herpetic disease of the mucous membranes, Herpes simplex skin and mucous membranes, Herpes simplex with skin and mucous membrane damage, Recurrent herpes, Urogenital herpetic infection, Chronic recurrent herpesvirus infection, Herpes-viral infections of various localizations

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

J01.9 Acute sinusitis, unspecified

Allergic sinusitis, Pain in sinusitis,Inflammation of the sinuses, catarrhal sinusitis, polypoid sinusitis, Sinusitis, acute sinusitis, genyantritis, purulent sinusitis

J06 Acute upper respiratory infections of multiple and unspecified

Frequent colds viral diseases, Infections of the upper respiratory tract, Acute respiratory disease influenza character, for colds Pain, Acute colds,Cold, respiratory infection,Seasonal colds, Pain in infectious and inflammatory diseases of the upper respiratory tract, Bacterial infections of the upper respiratory tract, Bacterial respiratory infections, Viral disease of the respiratory tract, Viral respiratory tract infections, Inflammatory disease of the upper respiratory tract, Inflammation of the upper respiratory tract disease, Inflammation of the upper respiratory tract illness with difficult sputum, Inflammatory airway disease, Secondary infections with colds, Shortness of sputum in acute and chronic respiratory diseases, Upper respiratory tract infection, Infections of the upper respiratory tract, Respiratory Tract Infections, Infections of the respiratory tract and lungs, Infectious-inflammatory diseases of the upper respiratory tract, Infectious-inflammatory diseases of the upper respiratory tract and ENT-organs, Infectious-inflammatory diseases of the upper respiratory tract in children and adults, Infectious-inflammatory diseases of the upper respiratory tract, Infectious inflammation of the airways,respiratory infection, Qatar upper respiratory tract, Catarrh of the upper respiratory tract, Catarrhal disease of the upper respiratory tract, Catarrhal symptoms of the upper respiratory tract, Coughing with a cold, SARS, ARI, ARI with rhinitis phenomena, Acute respiratory infection, Acute infectious and inflammatory disease of the upper respiratory tract, Acute respiratory disease, Sore throat or nose, Respiratory viral infections, Respiratory diseases, Respiratory infections, Recurrent respiratory infections, Secondary infection with influenza, cold in the chest, Feverish condition with flu usitis, acute sinusitis, genyantritis, purulent sinusitis

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

J32.9 Chronic sinusitis, unspecified

polypoid rhinosinusitis, Inflammation of the sinuses, Inflammation of the lateral sinuses

Composition

Cream 1 tube

salicylic acid; potassium iodide; zinc oxide; methyluracil; L-lysine; methyl and propyl esters of paraoxybenzoic acid; extract of celandine grass; sea-buckthorn oil

Description of dosage form

Cream with a light perfume smell of light cream color.

Action on the body

Antiseptic, antiviral, drying, purifying, regenerating, wound healing, weak keratolytic.

Component properties

With simple (herpes labialis, herpes nasalis) and genital herpes within 2-3 days from the beginning of application, localization of local symptoms in the form of tingling, burning, itching and pain in the area of rashes occurs. Accelerates as the transition from the bubble stage to the stage of formation of crusts (on the average, on the 3-4th day from the beginning of application), and complete epithelization (complete peeling of the crusts, on the average, on the 4th-5th day of application of Virosept). When used in complex herpes simplex therapy, symptom relief, the onset of epithelialization, and complete epithelialization occurred up to 39% faster. A decrease in the frequency of recurrence of simple and genital herpes with prophylactic use was noted (a decrease in the duration of the rash and an increase in the duration of the remission period). With preventive use, it reduces the frequency of recurrence of herpes by a factor of 4.3.

When applied to the affected areas of the skin, the cream softens and exfoliates the crusts, dries out the rashes, helping to reduce local edema and inflammation. The antiseptic components included in the cream have a wide spectrum of action, due to which the reproduction of the virus and the secondary bacterial infection that accompanies it are suppressed, which largely determines the duration of healing of skin rashes. The presence of sea buckthorn oil and methyluracil accelerates the healing and epithelization of the rashes.

Virosept can be recommended as a means of preventing respiratory-viral infections transmitted by airborne droplets. With a twice daily prophylactic application, it reduces the acute incidence by 3.3 times, reduces the average duration of the disease by 20%. The cream is applied to the outer parts of the nasal passages and blocks the penetration of the virus through the skin areas on the border with the nasal mucosa. In chronic sinusitis, it has an antiseptic effect and improves the separation of mucus from the paranasal sinuses.

Recommended

In complex therapy with simple and genital herpes; sinusitis, sinusitis; for the prevention of respiratory-viral infections transmitted by airborne droplets.

Contraindications

hypersensitivity to the components of the drug;

children's age (up to 2 years).

Side effects

Allergic reactions are possible.

Dosing and Administration

Outwardly. With herpes, the cream is applied to the area of rashes every 2-3 hours. When crusts are formed (3-4 days later), the cream is applied 2 times a day around the crusts formed for another 4-5 days. To prevent the recurrence of genital herpes, "Virosept" can be used as a means of personal hygiene.

For the prevention of acute respiratory viral infection and inflammation of the paranasal sinuses, apply a thin layer on the outer part of the nasal passages 2 times a day.

Form of issue

Cream. In plastic tubes of 10 ml.

Storage conditions

In a cool place.

Keep out of the reach of children.

Shelf Life Virosept

24 months

Do not use after the expiry date printed on the package.